Eighty-seven percent of HCC show intratumor heterogeneity with respect to morphology, immunohistochemistry and/or mutational status of CTNNB1 or TP53 (Friemel et al., 2015). The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.